These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Interferons: the pathways of discovery. II. Immunomodulatory, in vivo and applied aspects. Billiau A J Clin Virol; 2007 Aug; 39(4):241-65. PubMed ID: 17580123 [TBL] [Abstract][Full Text] [Related]
23. Treatment of multiple sclerosis with various interferons: the cons. Johnson KP Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576 [TBL] [Abstract][Full Text] [Related]
24. [Interferon in the treatment of viral, neoplastic and immunologic diseases]. Inglot AD Patol Pol; 1984; 35(3):245-61. PubMed ID: 6085509 [No Abstract] [Full Text] [Related]
25. Interferons: not just alpha. Krown SE Cancer Treat Rep; 1986 Dec; 70(12):1353-5. PubMed ID: 2431773 [No Abstract] [Full Text] [Related]
26. Interferon in viral hepatitis: role in pathogenesis and treatment. Davis GL; Hoofnagle JH Hepatology; 1986; 6(5):1038-41. PubMed ID: 2428722 [No Abstract] [Full Text] [Related]
32. The clinical implications of human interferon. Cesario TC Med Clin North Am; 1983 Sep; 67(5):1147-62. PubMed ID: 6413792 [No Abstract] [Full Text] [Related]
33. [Interferon in the treatment of viral hepatitis. The interferon was discovered 50 years ago]. Fehér J; Lengyel G Orv Hetil; 2007 Aug; 148(33):1539-43. PubMed ID: 17686671 [TBL] [Abstract][Full Text] [Related]
34. Recent advances in the study of interferon. Ho M Pharmacol Rev; 1982 Mar; 34(1):119-29. PubMed ID: 6175986 [No Abstract] [Full Text] [Related]
35. [The antiproliferative effects associated with vincristine and human interferons in experimental in vitro systems]. Danielescu G; Maniu H; Jucu V; Cajal N Virologie; 1989; 40(2):107-13. PubMed ID: 2506692 [TBL] [Abstract][Full Text] [Related]
37. [Interferon as a therapeutic agent]. Borecký L Cesk Farm; 1982 Jun; 31(5):184-7. PubMed ID: 6180842 [No Abstract] [Full Text] [Related]
38. The interferon system as a basis for antiviral therapy or prophylaxis. Billiau A Verh K Acad Geneeskd Belg; 1986; 48(3):187-220. PubMed ID: 2430375 [No Abstract] [Full Text] [Related]
39. Overview of the biology of type I interferons. Kalliolias GD; Ivashkiv LB Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S1. PubMed ID: 20392288 [TBL] [Abstract][Full Text] [Related]
40. [Interferon: its effects and clinical application]. Siegert R Internist (Berl); 1978 Dec; 19(12):659-63. PubMed ID: 370046 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]